Qube Research & Technologies LTD Abbott Laboratories Call Options Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $10.6 Million - $12.5 Million	106,200 Added 1930.91%	111,700 $12.7 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $2.55 Million - $2.84 Million	-25,300 Reduced 82.14%	5,500 $571,000
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $3.17 Million - $3.5 Million	28,900 Added 1521.05%	30,800 $3.5 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $171,361 - $209,760	1,900 New	1,900 $209,000
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $8.72 Million - $10.3 Million	90,000 New	90,000 $9.11 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $200B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.